YMAB icon

Y-mAbs Therapeutics
YMAB

Overview Fund Activity

98 hedge funds and large institutions have $107M invested in Y-mAbs Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+3
Holders Change %
+3.16%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
31
Reduced
36
Closed
6
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
-$9K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$2.26M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$4.42M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$1.32M
4
GCP
4
GSA Capital Partners
United Kingdom
$748K
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$7.35M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$434K
2
CSS
2
Cubist Systematic Strategies
Connecticut
$199K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$398K
4
AllianceBernstein
4
AllianceBernstein
Tennessee
$421K
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$1.95M
Name Holding Trade Value Shares
Change 		Shares
Change %
EGM
101
Engineers Gate Manager
New York
– -$95.7K -14,100 Closed
GCM
102
Graham Capital Management
Connecticut
– -$68.4K -10,075 Closed
QT
103
Quantbot Technologies
New York
– -$6.11K -900 Closed
1 2 3 4
5